logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-10. Distribution of clients entering treatment according to age and primary drug - EU overall summary in 2005 [see all tables in this series...]

Part (viii) Distribution of all inpatient clients by primary drug for each age group

Substance<1515-1920-2425-2930-3435-3940-4445+Age knownAge not known
Opioids0.821.146.958.956.450.444.623.51241822
Cocaine0.82.53.54.45.86.03.92.111010
Stimulants4.219.716.010.79.710.311.710.3333645
Hypnotics and sedatives5.06.04.57.311.916.922.146.33529559
Hallucinogens2.50.80.30.20.20.20.10.0711
Volatile substances24.47.82.31.41.00.90.60.754414
Cannabis 30.331.917.89.97.06.35.83.532022
Other substances 31.910.28.77.18.09.111.313.6244631
Total119243360546370416829751894263426647674

Notes:

 The countries supplying data are: 

 BG, CZ, DK, DE, IE, GR, CY, LU, HU, RO, SK, FI, SE, UK, TR 

 The number of treatment clients in each country is listed in [Table TDI-7]. 

 See also 'TDI-105-All inpatient age and primary drug.xls' on distribution by country and 'General notes for interpreting data' on the Explanatory notes and help page

Sources:

 2006 Reitox national reports - Table TDI inpatient treatment centres. 

Page last updated: Monday, 12 November 2007